DNA and Proliferation Analysis by Flow Cytometry

Cellular Diagnostics: Basic principles, methods and clinical applications of flow cytometry

Volumn , Issue , 2008, Pages 390-425

  Brockhoff, Gero ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66449095519     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000209173     Document Type: Chapter

References (98)

1. Otto FJ: High-resolution analysis of nuclear DNA employing the fluorochrome DAPI. Methods Cell Biol 1994;41:211-217.
2. Otto F: DAPI staining of fixed cells for high-resolution flow cytometry of nuclear DNA. Methods Cell Biol 1990;33:105-110.
3. Hemmer J,KraftK:High-resolutionDNAflowcytometry inoral verrucous carcinoma.Oncol Rep2000;7:433-435.
4. Hemmer J, van HeerdenWF, Polackova J, Kraft K: High-resolution DNA flow cytometry in papillary cystadenoma lymphomatosum (Warthin's tumour). J Oral Pathol Med 1998;27:405-406.
5. Wersto RP, Chrest FJ, Leary JF, Morris C, Stetler-Stevenson MA, Gabrielson E: Doublet discrimination in DNA cell-cycle analysis. Cytometry 2001;46:296-306.
6. Zellner A, Meixensberger J, Roggendorf W, Janka M, Hoehn H, Roosen K: DNA ploidy and cell-cycle analysis in intracranial meningiomas and hemangiopericytomas: a study with high-resolution DNA flow cytometry. Int J Cancer 1998;79:116-120.
7. Ferlini C, Biselli R, Scambia G, Fattorossi A: Probing chromatin structure in the early phases of apoptosis. Cell Prolif 1996;29:427-436.
8. Hemmer J, Thein T, Van Heerden WF: The value of DNA flow cytometry in predicting the development of lymph node metastasis and survival in patients with locally recurrent oral squamous cell carcinoma. Cancer 1997;79:2309-2313.
9. Bruno S, Crissman HA, Bauer KD, Darzynkiewicz Z: Changes in cell nuclei during S phase: progressive chromatin condensation and altered expression of the proliferation-associated nuclear proteins Ki-67, cyclin (PCNA), p 105, and p 34. Exp Cell Res 1991;196:99-106.
10. Crissman HA, Steinkamp JA: Rapid, simultaneous measurement of DNA, protein, and cell volume in single cells from large mammalian cell populations. J Cell Biol 1973;59:766-771.
11. Danova M, Riccardi A, Giordano M, Girino M, Mazzini G, Dezza L, Ascari E: Cell cycle-related proteins: a flow cytofluorometric study in human tumors. Biol Cell 1988 64:23-28.
12. DittrichW, Goehde W: Impulse fluorometry of single cells in suspension. Z Naturforsch B 1969;24:360-361.
13. Latt SA, George YS, Gray JW: Flow cytometric analysis of bromodeoxyuridine-substituted cells stained with 33258 Hoechst. J Histochem Cytochem 1977;25:927-934.
14. Nowak R, Oelschlagel U, Range U, Bergmann S, Bornhauser M, Holig C, Schuler U, Krebs U, Gunther H, Kroschinsky F, Ehninger G: Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy. Bone Marrow Transplant 1999;23:895-900.
15. Nowak R, Oelschlagel U, Range U, Molle M, Ehninger G: The incidence of DNA aneuploidy in multiple myeloma does not correlate with stage of disease. Am J Clin Pathol 1998;109:226-232.
16. Nowak R, Oelschlaegel U, Schuler U, Zengler H, Hofmann R, Ehninger G, Andreeff M: Sensitivity of combined DNA/immunophenotype flow cytometry for the detection of low levels of aneuploid lymphoblastic leukemia cells in bone marrow. Cytometry 1997;30:47-53.
17. Nowak R, Oelschlagel U, Hofmann R, Zengler H, Huhn R: Detection of aneuploid cells in acute lymphoblastic leukemia with flow cytometry before and after therapy. Leuk Res 1994;18:897-901.
18. Oelschlaegel U, Freund D, Range U, Ehninger G, Nowak R: Flow cytometric DNA-quantification of three-color immunophenotyped cells for subpopulation specific determination of aneuploidy and proliferation. J Immunol Methods 2001;253:145-152.
19. Brockhoff G, Endl E, Minuth W, Hofstdter F, Knuechel R: Options of flow cytometric three-colour DNA measurements to quantitate EGFR in subpopulations of human bladder cancer. Anal Cell Pathol 1996;11:55- 70.
20. Brockhoff G, Wieland W, Woelfl G, Hofstdter F, Knuechel R: Evaluation of flow-cytometric three-parameter analysis for EGFR quantification and DNA assessment in human bladder carcinomas. Virchows Arch 1998;432:77-84.
21. Bagwell CB, Clark GM, Spyratos F, Chassevent A, Bendahl PO, Stal O, Killander D, Jourdan ML, Romain S, Hunsberger B, Wright S, Baldetorp B: DNA and cell cycle analysis as prognostic indicators in breast tumors revisited. Clin Lab Med 2001;21:875-895.
22. Bagwell CB, Clark GM, Spyratos F, Chassevent A, Bendahl PO, Stal O, Killander D, Jourdan ML, Romain S, Hunsberger B, Baldetorp B: Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens. Cytometry 2001;46:121-135.
23. Bergers E, Baak JP, van Diest PJ, Willig AJ, Los J, Peterse JL, Ruitenberg HM, Schapers RF, Somsen JG, van Beek MW, Bellot SM, Fijnheer J, van Gorp LH: Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project. Mod Pathol 1997;10:762-768.
24. Bergers E, van Diest PJ, Baak JP: Reliable DNA histogram interpretation. Number of nuclei requiring measurement with flow cytometry. Anal Quant Cytol Histol 1997;19:277-284.
25. Bergers E, Baak JP, van Diest PJ, van Gorp LH, Kwee WS, Los J, Peterse HL, Ruitenberg HM, Schapers RF, Somsen JG, van Beek MW, Bellot SM, Fijnheer J: Prognostic implications of different cell cycle analysis models of flow cytometric DNA histograms of 1,301 breast cancer patients: results from the Multicenter Morphometric Mammary Carcinoma Project (MMMCP). Int J Cancer 1997;74:260-269.
26. Bergers E, van Diest PJ, Baak JP: Comparison of five cell cycle analysis models applied to 1,414 flow cytometric DNA histograms of fresh frozen breast cancer. Cytometry 1997;30:54-60.
27. Bergers E, van Diest PJ, Baak JP: Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry. J Clin Pathol 1996;49:931-937.
28. Bergers E, Montironi R, van Diest PJ, Prete E, Baak JP: Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases. Hum Pathol 1996;27:553-560.
29. Bergers E, van Diest PJ, Baak JP: Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Project Collaborative Group. Cancer 1996;77:2258-2266.
30. Bergers E, van Diest PJ, Baak JP: Reproducibility of semi-automated cell cycle analysis of flow cytometric DNAhistograms of fresh breast cancer material. Anal Cell Pathol 1995;8:1-13.
31. Brockhoff G, Fleischmann S, Meier A, Wachs FP, Hofstädter F, Knüchel R: Use of a mechanical dissociation device to improve standardization of flow cytometric cytokeratin DNA measurements of colon carcinomas. Cytometry 1999;38:184-191.
32. Corver WE, Koopman LA, van der Aa J, Regensburg M, Fleuren GJ, Cornelisse CJ: Four-color multiparameter DNA flow cytometric method to study phenotypic intratumor heterogeneity in cervical cancer. Cytometry 2000;39:96-107.
33. Corver WE, Bonsing BA, Abeln EC, Vlak-Theil PM, Cornelisse CJ, Fleuren GJ: One-tube triple staining method for flow cytometric analysis of DNA ploidy and phenotypic heterogeneity of human solid tumors using single laser excitation. Cytometry 1996;25:358-366.
34. Leers MP, Hoop JG, Nap M: Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry. Anticancer Res 2003;23:999-1006.
35. Leers MP, Theunissen PH, Schutte TB, Ramaekers FC: Bivariate cytokeratin/DNA flow cytometric analysis of paraffin-embedded samples from colorectal carcinomas. Cytometry 1995;21:101-107.
36. Corver WE, Cornelisse CJ, Hermans J, Fleuren GJ: Limited loss of nine tumor-associated surface antigenic determinants after tryptic cell dissociation. Cytometry 1995;19:267-272.
37. Vindelov LL: Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei. Virchows Arch B Cell Pathol 1977;24:227-242.
38. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J HistochemCytochem 1983;31:1333-1335.
39. Vindelov LL, Christensen IJ, Nissen NI: Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry 1983;3:328-331.
40. Corver WE, Koopman LA, Mulder A, Cornelisse CJ, Fleuren GJ: Distinction between HLA class I-positive and -negative cervical tumor subpopulations by multiparameter DNA flow cytometry. Cytometry 2000;41:73-80.
41. Corver WE, Fleuren GJ, Cornelisse CJ: Improved single laser measurement of two cellular antigens and DNAploidy by the combined use of propidium iodide and TO-PRO-3 iodide. Cytometry 1997;28:329-336.
42. Corver WE, Cornelisse CJ, Fleuren GJ: Simultaneous measurement of two cellular antigens and DNA using fluorescein- isothiocyanate, R-phycoerythrin, and propidium iodide on a standard FACScan. Cytometry 1994;15:117- 128.
43. Plander M, Brockhoff G, Barlage S, Schwarz S, Rothe G, Knuechel R: Optimization of three- and four-color multiparameter DNA analysis in lymphoma specimens. Cytometry 2003;54A:66-74.
44. Brockhoff G, Knchel R: Flow cytometric DNA-analysis in oncology: from single to multiparametric measurements. J Lab Med 2003;5-6:167-174.
45. Leers MP, Theunissen PH, Koudstaal J, Schutte B, Ramaekers FC: Trivariate flow cytometric analysis of paraffinembedded lung cancer specimens: application of cytokeratin subtype specific antibodies to distinguish between differentiation pathways. Cytometry 1997;27:179-188.
46. Sramkoski RM, Wormsley SW, Bolton WE, Crumpler DC, Jacobberger JW: Simultaneous detection of cyclin B1, p105, and DNA content provides complete cell cycle phase fraction analysis of cells that endoreduplicate. Cytometry 1999;35:274-283.
47. Endl E, Steinbach P, Knuechel R, Hofstaedter F: Analysis of cell cycle-related Ki-67 and p120 expression by flow cytometric BrdUrd-Hoechst/7AAD and immunolabeling technique. Cytometry 1997;29:233-241.
48. Bauer KD, Duque RE, Shankey TV: Clinical Flow Cytometry: Principles and Application. Baltimore, Williams & Wilkins, 1993.
49. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, Mayall BH, Wheeless L, Cox C: Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology. Cytometry 1993;14:472-477.
50. Hedley DW, Shankey TV, Wheeless LL: DNA cytometry consensus conference. Cytometry 1993;14:471.
51. Leers MP, Schutte B, Theunissen PH, Ramaekers FC, Nap M: Heat pretreatment increases resolution in DNA flow cytometry of paraffin-embedded tumor tissue. Cytometry 1999;35:260-266.
52. Leers MP, Theunissen PH, Ramaekers FC, Schutte B: Multi-parameter flow cytometric analysis with detection of the Ki67-Ag in paraffin embedded mammary carcinomas. Cytometry 1997;27:283-289.
53. Molnar B, Bocsi J, Karman J, Nemeth A, Pronai L, Zagoni T, Tulassay Z: Immediate DNA ploidy analysis of gastrointestinal biopsies taken by endoscopy using a mechanical dissociation device. Anticancer Res 2003;23:655- 660.
54. Nap M, Brockhoff G, Brandt B, Knchel R, Leers MP, Schmidt H, De Angelis G, Eltze E, Semjonow A: Flow cytometric DNA and phenotype analysis in pathology. A meeting report of a symposium at the annual conference of the German Society of Pathology, Kiel, Germany, 6-9 June 2000. Virchows Arch 2001;438:425-432.
55. Novelli M, Savoia P, Cambieri I, Ponti R, Comessatti A, Lisa F, Bernengo MG: Collagenase digestion and mechanical disaggregation as a method to extract and immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas. Clin Exp Dermatol 2000;25:423-431.
56. Bagwell CB, Mayo SW, Whetstone SD, Hitchcox SA, Baker DR, Herbert DJ, Weaver DL, Jones MA, Lovett EJ 3rd: DNA histogram debris theory and compensation. Cytometry 1991;12:107-118.
57. Corver WE, Fleuren GJ, Cornelisse CJ: Software compensation improves the analysis of heterogeneous tumor samples stained for multiparameter DNA flow cytometry. J Immunol Methods 2002;260:97-107.
58. Nowak R, Oelschlagel U, Heider T, Naumann R, Ehninger G: Some limitations in the detection of residual aneuploid cells with DNA quantification on immunophenotyped cells by flow cytometry. Br J Haematol 2000;110:751-753.
59. Ormerod MG, Tribukait B, Giaretti W: Consensus report of the task force on standardisation of DNA flow cytometry in clinical pathology. DNA Flow Cytometry Task Force of the European Society for Analytical Cellular Pathology. Anal Cell Pathol 1998;17:103-110.
60. Valet G: Past and present concepts in flow cytometry: a European perspective. J Biol Regul Homeost Agents 2003;17:213-222.
61. Valet GK, Tarnok A: Cytomics in predictive medicine. Cytometry 2003;53B:1-3.
62. Valet G: Predictive medicine by cytomics: potential and challenges. J Biol Regul Homeost Agents 2002;16:164- 167.
63. Baisch H, Beck HP, Christensen IJ, Hartmann NR, Fried J, Dean PN, Gray JW, Jett JH, Johnston DA, White RA, Nicolini C, Zeitz S, Watson JV: A comparison of mathematical methods for the analysis of DNA histograms obtained by flow cytometry. Cell Tissue Kinet 1982;15:235-249.
64. Dean PN, Jett JH: Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol 1974;60:523-527.
65. Brunsting A, Collins JM, Kane FR, Bagwell CB: An examination of some basic assumptions of DNA distribution analysis using biological data. Cell Tissue Kinet 1979;12:123-134.
66. Rabinovitch PS: DNA content histogram and cell-cycle analysis. Methods Cell Biol 1994;41:263-296.
67. Lacombe F, Belloc F, Bernard P, BoisseauMR: Evaluation of four methods of DNA distribution data analysis based on bromodeoxyuridine/DNA bivariate data. Cytometry 1988;9:245-253.
68. Beisker W, Dolbeare F, Gray JW: An improved immunocytochemical procedure for high-sensitivity detection of incorporated bromodeoxyuridine. Cytometry 1987;8:235-239.
69. Dean PN, Dolbeare F, Gratzner H, Rice GC, Gray JW: Cell-cycle analysis using a monoclonal antibody to BrdUrd. Cell Tissue Kinet 1984;17:427-436.
70. Dolbeare F, Gratzner H, Pallavicini MG, Gray JW: Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 1983;80:5573-5577.
71. Dolbeare F, Beisker W, Pallavicini MG, Vanderlaan M, Gray JW: Cytochemistry for bromodeoxyuridine/DNA analysis: stoichiometry and sensitivity. Cytometry 1985;6:521-530.
72. Gray JW, Dolbeare F, Pallavicini MG, Beisker W, Waldman F: Cell cycle analysis using flow cytometry. Int J Radiat Biol Relat Stud Phys ChemMed 1986;49:237-255.
73. Langer EM, Hemmer J, Kleinhans G, Goehde W: The applications of the BrdUrd-technique for the estimation of cycling S-phase cells in human renal cell carcinoma. Urol Res 1988;16:303-307.
74. Yanagisawa M, Dolbeare F, Todoroki T, Gray JW: Cell cycle analysis using numerical simulation of bivariate DNA/ bromodeoxyuridine distributions. Cytometry 1985;6:550-562.
75. Brockhoff G, Heiss P, Schlegel J, Hofstädter F, Knüchel R: Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells. Cytometry 2001;44:338-348.
76. Hammers HJ, Saballus M, Sheikzadeh S, Schlenke P: Introduction of a novel proliferation assay for pharmacological studies allowing the combination of BrdUdetection and phenotyping. J Immunol Methods 2002;264:89-93.
77. Hammers HJ, Kirchner H, Schlenke P: Ultraviolet-induced detection of halogenated pyrimidines: simultaneous analysis of DNA replication and cellular markers. Cytometry 2000;40:327-335.
78. Rabinovitch PS, Kubbies M, Chen YC, Schindler D, Hoehn H: BrdU-Hoechst flow cytometry: a unique tool for quantitative cell cycle analysis. Exp Cell Res 1988;174:309-318.
79. Kubbies M, Schindler D, Hoehn J, Rabinovitch PS: BrdU-Hoechst flow cytometry reveals regulation of human lymphocyte growth by donor age-related growth fraction and transition rate. J Cell Physiol 1985;125:229-234.
80. Latt SA, Sahar E, Eisenhard ME: Pairs of fluorescent dyes as probes of DNA and chromosomes. J Histochem Cytochem 1979;27:65-71.
81. Latt SA, Stetten G: Spectral studies on 33258 Hoechst and related bisbenzimidazole dyes useful for fluorescent detection of deoxyribonucleic acid synthesis. J Histochem Cytochem 1976;24:24-33.
82. Latt SA, Wohlleb JC: Optical studies of the interaction of 33258 Hoechst with DNA, chromatin, and metaphase chromosomes. Chromosoma 1975;52:297-316.
83. Diermeier S, Schmidt-Brcken E, Kubbies M, Kunz-Schughart LA, Brockhoff G: Continuous bromodeoxyuridine (BrdU) exposition differentially affects cell cycle progression of human breast and bladder cancer cell lines. Cell Prolif 2004;37:195-206.
84. Poot M, Hoehn H, Kubbies M, Grossmann A, Chen Y, Rabinovitch PS: Cell-cycle analysis using continuous bromodeoxyuridine labeling and Hoechst 33358-ethidium bromide bivariate flow cytometry. Methods Cell Biol 1994;41:327-340.
85. Poot M, Schindler D, Kubbies M, Hoehn H, Rabinovitch PS: Bromodeoxyuridine amplifies the inhibitory effect of oxygen on cell Proliferation. Cytometry 1988;9:332-338.
86. Kubbies M: High-resolution cell cycle analysis: The flow cytometric bromodeoxyuridine-Hoechst quenching technique; in Radbruch A (ed): Flow Cytometry and Cell Sorting, 2nd ed. Heidelberg, Springer, 1999, pp 112-124.
87. Ormerod MG, Kubbies M: Cell cycle analysis of asynchronous cell populations by flow cytometry using bromodeoxyuridine label and Hoechst-propidium iodide stain. Cytometry 1992;13:678-685.
88. Smith JA, Martin L: Do cells cycle Proc Natl Acad Sci U S A 1973;70:1263-1267.
89. Cleaver JE: Thymidine metabolism and cell kinetics; in Neuberger A, Tatum EL (eds): Frontiers of Biology. Amsterdam, North-Holland Publishing Company, 1967, vol 6, p 92.
90. Goz B: The effects of incorporation of 5-halogenated deoxyuridines into the DNA of eukaryotic cells. Pharmacol Rev 1977;29:249-272.
91. Kaufmann ER, Davidson RL: Biological and biochemical effects of bromodeoxyuridine and deoxycytidine on Syrian hamster melanoma cells. Somat Cell Genet 1978;4:587-601.
92. Kubbies M, Hoehn H, Schindler D Chen YC, Rabinovich PS: Cell cycle analysis via BrdUrd/Hoechst flow cytometry: principles and applications; in Yen A (ed): Flow Cytometry: Advanced Research and Clinical Application. Boca Raton, CRS-Press, 1989, vol 2, pp 5.
93. Peng DF, Sugihara H, Hattori T: Bromodeoxyuridine induces p53-dependent and -independent cell cycle arrests in human gastric carcinoma cell lines. Pathobiology 2001;69:77-85.
94. Beisker W, Weller-Mewe EM, Nuesse M: Fluorescence enhancement of DNA-bound TO-PRO-3 by incorporation of bromodeoxyuridine to monitor cell cycle kinetics. Cytometry 1999;37:221-229.
95. Corver WE, Ter Haar NT, Dreef EJ, Miranda NF, Prins FA, Jordanova ES, Cornelisse CJ, Fleuren GJ: High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin- embedded tissues. J Pathol 2005;206:233-241.
96. Diermeier S, Horváth G, Knuechel-Clarke R, Hofstaedter F, Szöllosi J, Brockhoff G. Epidermal growth factor receptor coexpression modulates susceptibility to herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation. Exp Cell Res 2005;304(2):604-19.
97. Brockhoff G, Heckel B, Schmidt-Bruecken E, Plander M, Hofstaedter F, Vollmann A, Diermeier S. Differential impact of cetuximab, pertuzumab and trastuzumab on BT474 and SK-BR-3breast cancer cell proliferation. Cell Prolif 2007;40:488-507.
98. Diermeier-Daucher S, Clarke ST, Bradford JA, Vollmann-Zwerenz A, Hill D, Brockhoff G: Applicability of EdU for dynamic proliferation assessment in Flow Cytometry, Submitted, 2008.